首页
400-620-6333
抗体
选项
-
Brentuximab (anti-TNFRSF8)关联靶标: TNFRSF8
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2088770-90-3 -
Brentuximab vedotin (anti-CD30)关联靶标: TNFRSF8
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号 : 914088-09-8SMILES: [Brentuximab vedotin] -
Recombinant CD30 Antibody (PE)关联靶标: TNFRSF8
- 简短描述: Recombinant; CD30 Antibody (PE); Flow
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: PE
-
Recombinant CD30 Antibody (APC)关联靶标: TNFRSF8
- 简短描述: Recombinant; CD30 Antibody (APC); Flow
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: APC
-
Samalizumab (anti-CD200)关联靶标: CD200
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1073059-33-2 -
Iratumumab (anti-CD30)关联靶标: TNFRSF8
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 640735-09-7 -
CD200/OX2 Rat mAb关联靶标: CD200
- 简短描述: mAb (OX-90); Rat anti Mouse CD200/OX2 Antibody; in vivo CD200 blockade, in vitro CD200 blockade, IHC, ICC, IF, Flow; Unconjugated
- 种属反应性: 小鼠(Mouse)
- 亚型: Rat IgG2a
- 宿主种属: 大鼠(Rat)
- 克隆号: OX-90
- 偶联: Unconjugated
